Targeting B cells for inflammatory bowel disease treatment: back to the future.


Journal

Current opinion in pharmacology
ISSN: 1471-4973
Titre abrégé: Curr Opin Pharmacol
Pays: England
ID NLM: 100966133

Informations de publication

Date de publication:
12 2020
Historique:
received: 08 06 2020
revised: 30 09 2020
accepted: 05 10 2020
pubmed: 10 11 2020
medline: 14 10 2021
entrez: 9 11 2020
Statut: ppublish

Résumé

B cells are critical to immune homeostasis at mucosal surfaces including those of the gastrointestinal tract. B cell-related abnormalities, comprising of a lympho-plasmacytic infiltrate, as well as anti-microbial antibodies, are well reported in patients with inflammatory bowel disease (IBD). However, B cell-targeting is not part of the therapeutic armamentarium in IBD. Recently, driven by the identification of genetic associations between IgG Fc receptors and IBD susceptibility, there has been renewed interest in defining the immunobiology of B cells during mucosal inflammation. Functional studies have demonstrated mechanisms of IgG-mediated disease pathogenesis and deep mucosal immunophenotyping using single cell RNA sequencing has elaborated a significant remodelling of the B cell compartment in IBD. In light of these novel data, here we discuss potential strategies to target B cell immunity in IBD. Finally, we discuss potential risks and pitfalls of these approaches and emphasize on distinguishing between homeostatic and pathological B cell signatures, allowing for a data-based, prudent therapeutic approach.

Identifiants

pubmed: 33166872
pii: S1471-4892(20)30100-4
doi: 10.1016/j.coph.2020.10.002
pmc: PMC7894973
mid: NIHMS1668326
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

90-98

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK112296
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

Ann Rheum Dis. 2015 Jul;74(7):1474-8
pubmed: 25710470
Immunity. 2015 Sep 15;43(3):541-53
pubmed: 26320660
Science. 2016 Mar 18;351(6279):1296-302
pubmed: 26989247
Int Immunol. 1997 Aug;9(8):1111-22
pubmed: 9263008
Ann N Y Acad Sci. 2018 Mar;1415(1):5-10
pubmed: 29291255
Front Immunol. 2019 Jul 10;10:1540
pubmed: 31354709
J Exp Med. 1996 Feb 1;183(2):693-8
pubmed: 8627184
Gut Microbes. 2020 Nov 9;12(1):1-9
pubmed: 31480888
Nature. 2012 Nov 1;491(7422):119-24
pubmed: 23128233
Nat Rev Gastroenterol Hepatol. 2014 Oct;11(10):588-600
pubmed: 24912389
Gastroenterology. 2012 Feb;142(2):257-65.e1-3
pubmed: 22062358
N Engl J Med. 2010 Apr 15;362(15):1383-95
pubmed: 20393175
Gastroenterology. 1987 Nov;93(5):919-24
pubmed: 3308623
Blood. 2018 Apr 5;131(14):1545-1555
pubmed: 29378696
PLoS Genet. 2013;9(1):e1003225
pubmed: 23382691
Gastroenterology. 2014 Jan;146(1):85-95; quiz e14-5
pubmed: 23735746
Aliment Pharmacol Ther. 2016 Jun;43(12):1300-10
pubmed: 27117843
J Immunol. 2012 Jul 1;189(1):92-101
pubmed: 22649202
Immunity. 2006 Aug;25(2):309-18
pubmed: 16919486
Clin Transl Gastroenterol. 2020 Apr;11(4):e00166
pubmed: 32352685
Nat Genet. 2015 Sep;47(9):979-986
pubmed: 26192919
Dig Dis Sci. 2016 Dec;61(12):3407-3424
pubmed: 27655102
J Cell Biol. 1994 Jun;125(6):1407-16
pubmed: 7515890
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5545-50
pubmed: 11960012
Gastroenterology. 2009 Nov;137(5):1746-56.e1
pubmed: 19664634
Nat Immunol. 2019 Aug;20(8):970-979
pubmed: 31235952
Lancet. 2017 Apr 29;389(10080):1756-1770
pubmed: 27914657
Adv Drug Deliv Rev. 2019 Feb 15;141:92-103
pubmed: 30552917
J Rheumatol. 2013 May;40(5):579-89
pubmed: 23547209
J Immunol. 2010 Aug 1;185(3):1577-83
pubmed: 20585032
Ann Rheum Dis. 2016 Apr;75(4):687-95
pubmed: 25795907
BMJ Open. 2019 Jan 28;9(1):e024523
pubmed: 30696682
Immunity. 2004 Jun;20(6):769-83
pubmed: 15189741
Nature. 2017 Apr 27;544(7651):498-502
pubmed: 28405025
Immunity. 2019 Apr 16;50(4):1099-1114.e10
pubmed: 30876876
Front Immunol. 2014 Oct 20;5:520
pubmed: 25368619
Am J Gastroenterol. 2008 Feb;103(2):386-96
pubmed: 17924999
Sci Transl Med. 2017 Nov 1;9(414):
pubmed: 29093180
J Clin Invest. 2018 Oct 1;128(10):4372-4386
pubmed: 30040076
Gastroenterology. 2020 Jan;158(1):95-110
pubmed: 31626754
Scand J Gastroenterol. 2017 May;52(5):606-608
pubmed: 28129697
Front Immunol. 2018 Jun 04;9:1228
pubmed: 29915586
Nat Commun. 2018 Mar 23;9(1):1200
pubmed: 29572471
Gut. 1996 Mar;38(3):365-75
pubmed: 8675088
Ann Rheum Dis. 2019 Jun;78(6):754-760
pubmed: 30902820
Inflamm Bowel Dis. 2017 Jul;23(7):1080-1087
pubmed: 28452863
Gastroenterology. 2018 Sep;155(3):829-843
pubmed: 29792883
Sci Transl Med. 2018 Oct 3;10(461):
pubmed: 30282696
Cell Host Microbe. 2015 May 13;17(5):617-27
pubmed: 25936799
Am J Gastroenterol. 2010 Aug;105(8):1811-9
pubmed: 20197757
Lancet. 2011 Feb 26;377(9767):721-31
pubmed: 21296403
Gastroenterology. 2009 Apr;136(4):1261-71, e1-3
pubmed: 19230854
Science. 2009 Jul 31;325(5940):617-20
pubmed: 19644121
Immunity. 2017 Jul 18;47(1):118-134.e8
pubmed: 28709802
Clin Exp Immunol. 2000 Sep;121(3):466-71
pubmed: 10971512
Nat Rev Immunol. 2008 Jun;8(6):458-66
pubmed: 18500230
Cell. 2019 Nov 14;179(5):1160-1176.e24
pubmed: 31730855
Immunity. 2016 May 17;44(5):1005-19
pubmed: 27192566
Immunity. 2018 Aug 21;49(2):211-224
pubmed: 30134201
Immunity. 2019 May 21;50(5):1172-1187.e7
pubmed: 31076359
Nat Immunol. 2015 Aug;16(8):880-8
pubmed: 26147688
Annu Rev Immunol. 2010;28:573-621
pubmed: 20192811
Nat Rev Rheumatol. 2016 Jan;12(1):49-62
pubmed: 26656660
Nat Commun. 2019 Jun 19;10(1):2686
pubmed: 31217423
J Immunol. 2011 Apr 1;186(7):4234-43
pubmed: 21383241
Annu Rev Immunol. 2008;26:513-33
pubmed: 18370923
N Engl J Med. 2019 Sep 26;381(13):1201-1214
pubmed: 31553833
Immunity. 2013 Dec 12;39(6):1095-107
pubmed: 24290911
N Engl J Med. 2012 Oct 18;367(16):1519-28
pubmed: 23075178
N Engl J Med. 2005 Dec 8;353(23):2462-76
pubmed: 16339095
Gut. 2017 Jun;66(6):1049-1059
pubmed: 28209624
Lancet. 2017 Apr 29;389(10080):1741-1755
pubmed: 27914655
Gut. 1998 Jun;42(6):788-91
pubmed: 9691915
Am J Gastroenterol. 2002 Jun;97(6):1458-62
pubmed: 12094865
Cell Host Microbe. 2007 Nov 15;2(5):328-39
pubmed: 18005754
Cell. 2019 Jul 25;178(3):714-730.e22
pubmed: 31348891
Clin Exp Rheumatol. 2016 Mar-Apr;34(2):318-28
pubmed: 26966791
Transpl Int. 2014 Feb;27(2):117-28
pubmed: 23909582
Inflamm Bowel Dis. 2015 Jun;21(6):1237-47
pubmed: 25895110
N Engl J Med. 2004 Feb 26;350(9):876-85
pubmed: 14985485
Cell. 2019 Sep 5;178(6):1493-1508.e20
pubmed: 31474370
N Engl J Med. 2019 Sep 26;381(13):1215-1226
pubmed: 31553834
Cell. 2016 May 5;165(4):827-41
pubmed: 27153495
Gastroenterology. 1974 Jun;66(6):1123-36
pubmed: 4829119
Gut. 1994 Feb;35(2):224-30
pubmed: 8307474
Gastroenterology. 2018 Apr;154(5):1320-1333.e10
pubmed: 29309774
Eur J Clin Pharmacol. 2018 Feb;74(2):161-169
pubmed: 29127458
Nat Rev Immunol. 2008 Jun;8(6):421-34
pubmed: 18483500
Gut. 2011 Nov;60(11):1520-6
pubmed: 21471566
Nat Immunol. 2017 Jan;18(1):104-113
pubmed: 27820809
Gut. 2013 Dec;62(12):1734-44
pubmed: 23013725
Ann Rheum Dis. 2014 Dec;73(12):2213-5
pubmed: 25157177
Clin Exp Immunol. 1975 Nov;22(2):197-209
pubmed: 1082398
Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7007-11
pubmed: 7518925
Aliment Pharmacol Ther. 2005 Jul 15;22(2):111-22
pubmed: 16011669
J Exp Med. 2018 Jan 2;215(1):91-113
pubmed: 29158374
Blood. 2009 Apr 16;113(16):3716-25
pubmed: 19018092
CEN Case Rep. 2019 Feb;8(1):55-60
pubmed: 30251194
Lancet. 2018 Jun 30;391(10140):2619-2630
pubmed: 29910042

Auteurs

Tomas Castro-Dopico (T)

Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Precision Institute of Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK.

Jean-Frederic Colombel (JF)

Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Saurabh Mehandru (S)

Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Precision Institute of Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: saurabh.mehandru@mssm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH